Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research

Cent Afr J Med. 2015 Sep-Dec;61(9-12):76-83.

Abstract

Postpartum Haemorrhage (PPH) is the most common cause of maternal mortality globally, leading to a woman's death every seven minutes. In Zimbabwe, there has been a 300% increase in the Maternal Mortality Ratio (MMR) between 1994 and 2010 and the MMR was estimated at 960 maternal deaths per 100,000 live births in 2012.2-3 Overall, 14% of all maternal deaths in Zimbabwe are due to PPH. Ensuring prompt access to high-quality prevention and treatment of PPH for all women who deliver is an essential strategy to combat PPH-related morbidity and mortality and to make progress toward reaching Millennium Development Goal 5, the reduction of maternal mortality by three-quarters by 2015.

Publication types

  • Review

MeSH terms

  • Female
  • Health Services Accessibility
  • Humans
  • Maternal Death / prevention & control
  • Maternal Death / statistics & numerical data
  • Maternal Mortality / trends
  • Misoprostol / therapeutic use*
  • Operations Research
  • Oxytocics / therapeutic use*
  • Postpartum Hemorrhage / drug therapy*
  • Postpartum Hemorrhage / mortality
  • Pregnancy
  • Zimbabwe / epidemiology

Substances

  • Oxytocics
  • Misoprostol